106 studies found for:    mozobil
Show Display Options
Rank Status Study
1 Recruiting Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
Conditions: High Grade Glioma: Glioblastoma (GBM);   High Grade Glioma: Gliosarcoma;   Anaplastic Astrocytoma (AA);   Anaplastic Oligodendroglioma (AO);   Mixed Anaplastic Oligoastrocytoma (AOA)
Interventions: Drug: Plerixafor;   Drug: Bevacizumab;   Procedure: Surgery
2 Completed
Has Results
AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts
Condition: Autologous Stem Cell Transplantation
Intervention: Drug: G-CSF plus plerixafor
3 Completed AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: AMD3100;   Drug: Mitoxantrone;   Drug: Etoposide;   Drug: Cytarabine
4 Completed
Has Results
The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD)
Conditions: Non-Hodgkin Lymphoma;   Hodgkin Disease
Interventions: Drug: G-CSF plus plerixafor;   Biological: rituximab
5 Recruiting Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Plerixafor (AMD3100);   Drug: bortezomib
6 Completed
Has Results
AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF
Conditions: Multiple Myeloma;   Lymphoma, Non-Hodgkin
Intervention: Drug: G-CSF Plus Plerixafor
7 Recruiting Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major
Condition: Beta-Thalassemia
Intervention: Drug: Mozobil
8 Unknown  Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor
Condition: Malignant Lymphoma, Stem Cell Type
Interventions: Drug: Plerixafor (Mozobil);   Drug: Plerixafor + G-CSF
9 Completed
Has Results
Alteration in Timing of Plerixafor Administration
Condition: Autologous Transplantation
Intervention: Drug: Plerixafor
10 Unknown  Feasibility and Efficiency Study of Leukemic Cell Mobilization With Plerixafor Injection
Condition: Acute Myeloid Leukemia
Intervention: Drug: Plerixafor (mozobil)
11 Completed Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Chronic Lymphocytic Leukemia (CLL);   Small Lymphocytic Lymphoma (SLL)
Intervention: Drug: plerixafor
12 Completed
Has Results
AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Drug: G-CSF Plus Plerixafor
13 Completed
Has Results
Safety, Pharmacokinetics (PK), And Hematological Activity Of AMD3100 (Plerixafor) In Subjects With Renal Impairment
Condition: Renal Impairment
Intervention: Drug: plerixafor
14 Terminated
Has Results
AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone
Conditions: Multiple Myeloma;   Lymphoma, Non-Hodgkin's
Intervention: Drug: G-CSF plus plerixafor
15 Completed
Has Results
Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
Conditions: Lymphoma, Non-Hodgkin;   Multiple Myeloma
Intervention: Drug: G-CSF Plus Plerixafor
16 Completed Trial of an Augmented Mobilization Strategy With Plerixafor (Mozobil®) in a Population at Risk for Poor Stem Cell Mobilization
Conditions: Multiple Myeloma;   Lymphoma
Interventions: Drug: Plerixafor;   Other: Observation: Nonintervention
17 Completed
Has Results
Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
Conditions: Lymphoma, Non-Hodgkin;   Multiple Myeloma
Intervention: Drug: G-CSF Plus Plerixafor
18 Completed
Has Results
AMD 3100 for Treatment of Myelokathexis
Condition: Neutropenia
Intervention: Drug: AMD3100 or plerixafor
19 Not yet recruiting Bioequivalence Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma
Conditions: Multiple Myeloma;   Lymphoma, Non-Hodgkin
Interventions: Drug: XOM Filgrastim and Plerixafor;   Drug: Filgrastim and Plerixafor;   Procedure: Apheresis
20 Active, not recruiting Mozobil for Autologous Stem Cell Mobilization
Conditions: Non-Hodgkin's Lymphoma;   Hodgkin's Lymphoma;   Stem Cell Mobilization;   Autologous Stem Cell Transplantation
Intervention: Drug: Plerixafor

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years